Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Medpace Holdings Inc (MEDP) vs Super Micro Computer Inc (SMCI) Price & Performance

Medpace Holdings IncTrade
Super Micro Computer IncTrade

Price performance (Past 24H)

Key statistics

Medpace Holdings Inc vs Super Micro Computer Inc — how do they compare? Medpace Holdings Inc trades at $611.57 (market cap $16.82B), while Super Micro Computer Inc trades at $41.85 (market cap $28.10B). The key difference: Super Micro Computer Inc is the larger of the two by market cap, and Medpace Holdings Inc is trading nearer its 52-week high, Super Micro Computer Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Medpace Holdings Inc for 14 Days and Super Micro Computer Inc for 19 Days on average.

MEDPSMCI
Market Cap
$16.82B$28.10B
Volume
223,09338,581,805
Sector
HealthTechnology
52-Week High
$630.19$57.98
52-Week Low
$393.42$20.53
Typical Hold Time
14 Days19 Days
Enterprise Value
$16.44B$33.56B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Medpace Holdings Inc

Medpace (MEDP) trades at $617.47, up 2.19% with strong quarterly earnings beats and robust profitability metrics. The stock shows neutral technical signals with key resistance at $620, while fundamentals reveal impressive ROE of 162.15% and consistent revenue growth to $2.8B projected for 2026. Recent CEO stock sales and mixed institutional activity create balanced sentiment ahead of Q3 earnings announcement on October 21, 2026.

MEDP presents growth potential with analyst consensus target of $620.44 and strong historical execution, though elevated valuations (P/E 35.41) and insider selling warrant caution. The stock's upside depends on continued earnings delivery amid competitive medical services landscape.

Super Micro Computer Inc

Super Micro Computer (SMCI) trades at $41.34, down 8.03% in the last session, but maintains strong fundamental performance with consistent earnings beats and robust revenue growth projections. The stock shows bullish technical signals with support at $40 and resistance at $44, while valuation metrics remain attractive with a P/E of 13.12 and P/S of 0.76. Recent news highlights AI server demand growth and new NVIDIA Vera Rubin platform shipments.

SMCI presents a compelling value opportunity with strong AI-driven growth prospects, though investors face risks from competitive pressures and potential regulatory scrutiny. Analyst consensus leans neutral with a $42.33 price target, while institutional interest remains strong given the company's positioning in the expanding AI infrastructure market.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MEDP
100% Buy0% Sell
Avg holding period · 14 Days
SMCI
47% Buy53% Sell
Avg holding period · 19 Days

Top news

Latest headlines on both assets

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Read more on MEDP →

About Super Micro Computer Inc

Super Micro Computer, Inc., commonly known as Supermicro, is a leading provider of high-performance and high-efficiency server technology and innovation. The company specializes in designing, manufacturing, and selling advanced server, storage, and networking solutions, primarily for data centers, cloud computing, artificial intelligence, and 5G/Edge computing markets. SMCI's modular architecture allows for the rapid delivery of customized and purpose-built solutions, making it a key player in the enterprise computing and specialized AI infrastructure space.

Read more on SMCI →